Eicosapentanoic Acid
Obesity, Abdominal
Technological Centre of Nutrition and Health, SpainPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Obesity, Abdominal cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin RenJi Hospital | Phase 4 | BBB |
UMBELLATINE China National Center for Cardiovascular Diseases | Phase 4 | BB |
Letrozole RenJi Hospital | Phase 4 | BB |
17-beta-estradiol University of Colorado, Denver | Phase 4 | BB |
VITAMIN D Alborz Medical University | Phase 2 | B |
View all 17 →
Same molecule, other indications
Eicosapentanoic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →